Technion researchers have successfully established a new approach for pacing the heart and synchronizing its mechanical activity without the use of a conventional electrical pacemaker. This novel biologic strategy employs light-sensitive genes that can be injected into the heart and then activated by flashes of blue light.
More than 3 million people worldwide have had electronic pacemakers implanted. The most common indication for a pacemaker is the treatment of a slow heart beat which can put patients at risk for fainting, heart failure, and even death. Pacemakers work by sending electrical signals to the heart to regulate the heart beat. Pacemakers can also be used for cardiac resynchronization therapy (CRT), an approach aiming to synchronize the contraction of the heart’s two ventricles in order to improve heart function, symptom status and decrease mortality in some patients who suffer from heart failure.
The new optogenetic approach for cardiac pacing and resynchronization was developed by Prof. Lior Gepstein and Dr. Udi Nussinovitch of the Technion-Israel Institute of Technology’s Rappaport Faculty of Medicine, and Rambam Medical Center.
“Our work is the first to suggest a non-electrical approach to cardiac resynchronization therapy,” Gepstein said. “Before this, there have been a number of elegant gene therapy and cell therapy approaches for generating biological pacemakers that can pace the heart from a single spot. However it was impossible to use such approaches to activate the heart simultaneously from a number of sites for resynchronization therapy.”
If the biological pacemaker can be adapted for humans, it could help patients avoid many of the drawbacks of electrical pacemakers. These include the surgical procedure needed to implant the device, the risk of infection, the limitation on the number and locations of the pacing wires used, the possible decline in cardiac function resulting from the change in the normal electrical activation pattern, and the limitations on implantation in children.
“This is a very important proof-of-concept experiment, which for the first time, demonstrates a mechanism to pace the heart without the need for wires and allows for simultaneous pacing from multiple sites,” said Dr. Jeffrey Olgin, chief of the Division of Cardiology and co-director of the Heart and Vascular Center at the University of California, San Francisco. “The most common site of failure of current pacemakers are the leads or wires that connect the heart muscle to the electrical impulse. The approach demonstrated in this paper has the potential to eliminate these wires or have a single lead excite multiple sites simultaneously.”
Pacing the heart with light is part of the emerging field of optogenetics, which has gained considerable momentum in the field of brain research. Researchers working in the field have been taking light-sensitive genes from algae and placing them in cells where they act like a switch, turning certain behaviors on or off when the cells are exposed to pulses of light.
As they report in the journal Nature Biotechnology, the Technion researchers injected one of these algae genes (channelorhodopsin-2) into a specific area of rat heart muscle. The scientists then showed that the light-sensitive protein expressed at this site could be turned on with flashes of blue light and drive the heart muscle to contract. By altering the frequency of the flashes, Gepstein and Nussinovitch could control and regulate the heart rate. They went on to deliver the gene to several places in the heart’s pumping chambers, and demonstrated the ability to simultaneously activate the heart muscle from many places in an effort to synchronize the heart’s pumping function.
Scientists will need to do more research for this optogenetic-based pacemaker strategy to become a reality in human health, Gepstein said. For instance, the gene injected in the rat experiments is sensitive to blue light which has poor tissue penetration potentially limiting its utility in large animals or humans.
“This means that the affected cells have to be relatively superficial–near the surface of the heart–and that an optical fiber should be implanted bringing the illumination beam as close as possible to the cells,” Gepstein said. “A potential solution in the future may be the development of similar light-sensitive proteins that will be responsive to light in the near-red or even infra-red spectrum, which penetrates tissue much better, allowing illumination from a long distance.”
Read more: BLUE LIGHT SETS THE BEAT IN BIOLOGICAL PACEMAKER
The Latest on: Biological Pacemaker
[google_news title=”” keyword=”Biological Pacemaker” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Biological Pacemaker
- Identity Pacemaker from St. Jude Medicalon May 8, 2024 at 5:00 pm
The Identity pacemaker models 5370 and 5376 feature AF management, a suite of therapeutic and diagnostic capabilities designed to manage pacemaker patients suffering from AF. This tool kit includes: ...
- Evaluating MRI-Compatible Pacemakerson May 7, 2024 at 5:00 pm
New pacing systems have recently been specifically designed by the major companies for safe use in the MRI environment (EnRhythm, Advisa, and Revo MRI SureScan pacemakers and CapSureFix MRI leads ...
- Beware What You Wear With Your Pacemaker or ICDon May 7, 2024 at 5:00 pm
Relatively weak magnets in consumer products have always posed some risk, usually very low, to the function of pacemakers and implantable cardioverter-defibrillators (ICDs). However, stronger ...
- Organic electrochemical transistors: Scientists solve chemical mystery at the interface of biology and technologyon April 30, 2024 at 11:22 am
Researchers who want to bridge the divide between biology and technology spend a lot of time thinking about translating between the two different "languages" of those realms.
- The relationship between calcium consumption at various times of the day and cardiovascular diseaseon April 24, 2024 at 12:13 am
However, the relationship between calcium consumption at various times of the day and cardiovascular disease is unclear. The present study examined the relationship between dietary calcium consumption ...
- Pacemaker or competitor? Beijing half marathon under probe as Chinese star handed a winon April 17, 2024 at 12:16 am
Six hours later, Mnangat changed his story, telling BBC Sport Africa that he “allowed He to win” because he was hired to serve as a “pacemaker” and he “was not there to compete.” ...
- Your body has an internal clock that dictates when you eat, sleep and might have a heart attack – all based on time of dayon April 6, 2024 at 5:00 pm
Anyone who has suffered from jet lag or struggled after turning the clock forward or back an hour for daylight saving time knows all about what researchers call your biological clock, or circadian ...
- Arnold Schwarzenegger just got a pacemaker. Here's what to know about the heart device that makes him 'a little bit more of a machine.'on March 26, 2024 at 3:48 pm
A pacemaker is a small, battery-powered device that controls the heartbeat. Our heartbeats are controlled by a highly efficient, biological electrical system that ensures our heart steadily pumps ...
- Arnold Schwarzenegger just got a pacemaker. Here's what to know about the heart device that makes him 'a little bit more of a machine.'on March 25, 2024 at 5:00 pm
A pacemaker is a small, battery-powered device that controls the heartbeat. Our heartbeats are controlled by a highly efficient, biological electrical system that ensures our heart steadily pumps ...
- Perseverance keeps LA DACA recipient on track to become a doctoron September 29, 2023 at 4:41 pm
a project Marbán and Cingolani call “biological pacemaker.” Upon completing her doctorate, Sanchez wants to have her own lab and become a principal investigator so she, too, can help and ...
via Bing News